Development and validation of a breast cancer risk prediction model for Thai women: a cross-sectional study.

BACKGROUND Breast cancer risk prediction models are widely used in clinical practice. They should be useful in identifying high risk women for screening in limited-resource countries. However, previous models showed poor performance in derived and validated settings. Therefore, we aimed to develop and validate a breast cancer risk prediction model for Thai women. MATERIALS AND METHODS This cross-sectional study consisted of derived and validation phases. Data collected at Ramathibodi and other two hospitals were used for deriving and externally validating models, respectively. Multiple logistic regression was applied to construct the model. Calibration and discrimination performances were assessed using the observed/expected ratio and concordance statistic (C-statistic), respectively. A bootstrap with 200 repetitions was applied for internal validation. RESULTS Age, menopausal status, body mass index, and use of oral contraceptives were significantly associated with breast cancer and were included in the model. Observed/expected ratio and C-statistic were 1.00 (95% CI: 0.82, 1.21) and 0.651 (95% CI: 0.595, 0.707), respectively. Internal validation showed good performance with a bias of 0.010 (95% CI: 0.002, 0.018) and C-statistic of 0.646(95% CI: 0.642, 0.650). The observed/expected ratio and C-statistic from external validation were 0.97 (95% CI: 0.68, 1.35) and 0.609 (95% CI: 0.511, 0.706), respectively. Risk scores were created and was stratified as low (0-0.86), low-intermediate (0.87-1.14), intermediate-high (1.15-1.52), and high-risk (1.53-3.40) groups. CONCLUSIONS A Thai breast cancer risk prediction model was created with good calibration and fair discrimination performance. Risk stratification should aid to prioritize high risk women to receive an organized breast cancer screening program in Thailand and other limited-resource countries.

[1]  H. Nelson,et al.  Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[2]  D G Altman,et al.  What do we mean by validating a prognostic model? , 2000, Statistics in medicine.

[3]  P. Gøtzsche,et al.  Screening for breast cancer with mammography. , 2013, The Cochrane database of systematic reviews.

[4]  Changhua Wang,et al.  Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[5]  M. García-Closas,et al.  Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  P. Hartge,et al.  Effect of changing breast cancer incidence rates on the calibration of the Gail model. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  N. Tsakountakis,et al.  Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status , 2005, BMC Women's Health.

[8]  S. Sangrajrang,et al.  Obesity, diet and physical inactivity and risk of breast cancer in Thai women. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[9]  Monica Morrow,et al.  Presenting Features of Breast Cancer Differ by Molecular Subtype , 2009, Annals of Surgical Oncology.

[10]  Ming Wu,et al.  Incidence and mortality of female breast cancer in Jiangsu, China. , 2014, Asian Pacific Journal of Cancer Prevention.

[11]  H. Boshuizen,et al.  Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.

[12]  J. Cuzick,et al.  American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction. , 2009, Journal of oncology practice.

[13]  Michael J Kerin,et al.  Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer , 2010, Annals of surgery.

[14]  G A Colditz,et al.  Nurses' health study: log-incidence mathematical model of breast cancer incidence. , 1996, Journal of the National Cancer Institute.

[15]  Yaogang Wang,et al.  Tea consumption, alcohol drinking and physical activity associations with breast cancer risk among Chinese females: a systematic review and meta-analysis. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[16]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[17]  C. Kirwan Breast cancer screening: what does the future hold? , 2013, BMJ.

[18]  S. Ahn,et al.  Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. , 2006, Archives of surgery.

[19]  Marcello Tonelli,et al.  Recommendations on screening for breast cancer in average-risk women aged 40–74 years , 2011, Canadian Medical Association Journal.

[20]  C. Yip,et al.  Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative. , 2011, Breast.

[21]  Ammarin Thakkinstian,et al.  Risk prediction models of breast cancer: a systematic review of model performances , 2012, Breast Cancer Research and Treatment.

[22]  Yulia V. Marchenko,et al.  Diagnostics for Multiple Imputation in Stata , 2012 .

[23]  D. Guldal,et al.  Family history attributes and risk factors for breast cancer in Turkey. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[24]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[25]  G. Farshid,et al.  Influence of mammographic screening on breast cancer incidence trends in South Australia. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[26]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[27]  W. Han,et al.  Young age: an independent risk factor for disease-free survival in women with operable breast cancer , 2004, BMC Cancer.

[28]  T. Anothaisintawee,et al.  Risk Factors of Breast Cancer , 2013, Asia-Pacific journal of public health.

[29]  A. Mosavi-Jarrahi,et al.  Trends in incidence of breast cancer among women under 40 in Asia. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[30]  E. Chang,et al.  Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry , 2011, Breast Cancer Research and Treatment.

[31]  D B Rubin,et al.  Multiple imputation in health-care databases: an overview and some applications. , 1991, Statistics in medicine.

[32]  C. Yip Breast cancer in Asia. , 2009, Methods in molecular biology.

[33]  V. Sirivatanauksorn,et al.  Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[34]  M Schumacher,et al.  Resampling and cross-validation techniques: a tool to reduce bias caused by model building? , 1997, Statistics in medicine.

[35]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[36]  Marilys Corbex,et al.  Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative. , 2011, Breast.

[37]  D. Altman,et al.  The benefits and harms of breast cancer screening: an independent review , 2012, British Journal of Cancer.